Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model

International Journal of Cancer

Volumn 100, Issue 4, 2002, Pages 381-387

  Clement, Paul M J ^a   Hanauske Abel, Hartmut M ^a   Wolff, Edith C ^a   Kleinman, Hynda K ^b   Park, Myung Hee ^a,b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Bone metastasis; Breast cancer; Epidermal growth factor receptor; Ipriflavone; Isoflavone; Osteoclast; Tyrosine kinase inhibitor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; IPRIFLAVONE; ISOFLAVONE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE METASTASIS; BREAST CANCER; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANALGESICS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BONE NEOPLASMS; BREAST NEOPLASMS; CELL DIVISION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; ISOFLAVONES; MICE; MICE, INBRED ICR; MICE, NUDE; MITOTIC INDEX; NEOPLASM METASTASIS; OSTEOCLASTS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TREATMENT OUTCOME; TYROSINE;

EID: 0036681441     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10517     Document Type: Article

References (46)

1. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone
2. Biology of osteoclast activation in cancer
3. Breast cancer cells interact with osteoblasts to support osteoclast formation
4. Cancer and bone
5. Current use of bisphosphonates in oncology
6. Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomized, placebo-controlled trial
7. Bisphosphonates and the prevention of metastasis
8. The potential role of bisphosphonates as adjuvant therapy in the prevention of bone metastases
9. Bisphosphonate treatment inhibits the growth of prostate cancer cells
10. The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases
11. The effect of ipriflavone (TC-80) on bone resorption in tissue culture
12. Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells
13. Ipriflavone directly inhibits osteoclastic activity
14. Inhibition of parathyroid hormone-stimulated resorption in cultured fetal rat long bones by the main metabolites of ipriflavone
15. Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line
16. Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture
17. Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites
18. Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats
19. Calcitonin secreting property of ipriflavone in the presence of estrogen
20. Ipriflavone: An important bone-building isoflavone
21. Effect of ipriflavone, a synthetic derivative of natural isoflavones, on bone mass loss in the early years after menopause
22. Effects of 1-year ipriflavone treatment on lumbar bone mineral density and bone metabolic markers in postmenopausal women with low bone mass
23. Ipriflavone in the treatment of postmenopausal osteoporosis. A randomized controlled trial
24. Use and specificity of genistein as inhibitor of protein-tyrosine kinases
25. Genistein as an inducer of tumor cell differentiation: Possible mechanisms of action
26. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein
27. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition
28. Differentiation of promyelocytic leukemia cells HL-60 induced by daidzein in vitro and in vivo
29. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor ß
30. G-nitro-L-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model
31. Breast tumor cell lines from pleural effusions
32. Interleukin-18 inhibits osteolytic bone metastasis by human lung cancer cells possibly through suppression of osteoclastic bone-resorption in nude mice
33. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells
34. Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1
35. Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin in MM1 cancer cell migration
36. Ipriflavone as an inhibitor of human cytochrome P450 enzymes
37. Evidence for a growth effect of epidermal growth factor on MDA-MB-231 breast cancer cells
38. 1101 is associated with modulation of receptor function
39. Cellular and molecular mechanisms of action of bisphosphonates
40. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice
41. Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function
42. Genistein, a specific inhibitor of tyrosine-specific protein kinases
43. Quercetin inhibits the invasion and mobility of murine melanoma B16-BL6 cells through inducing apoptosis via decreasing Bcl-2 expression
44. The inhibitory effect of genistein on the growth and metastasis of a transplantable rat accessory sex gland carcinoma
45. Legumes and soybeans: Overview of their nutritional profiles and health effects
46. Oral ipriflavone (7-isopropoxy-isoflavone) treatment for elderly patients with resistant acute leukemias